News

Public Broadcasting Service (PBS)1d
EPA eliminates research and development office as it begins thousands of layoffs
The Environmental Protection Agency said Friday it is eliminating its research and development arm and reducing agency staff ...
EconoTimes1d
Trump 2026 Budget Plan’s NIH Cuts Could Slow Drug Development, CBO Warns
The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...
Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Medical Marketing & Media2d
Rx Rundown: Sarep­ta Ther­a­peu­tics, Juul, Pfizer and more
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
State Department firings will hit Trump admin’s ability to tackle its own priorities, sources say
The mass firing of State Department employees could significantly impact the Trump administration’s ability to address the ...
Government Executive5d
Some agencies are walking back planned layoffs, Trump administration says
Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.
Undark Magazine6d
Safety of Foreign-Made Medications in Question After FDA Layoffs
Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
Becker's Hospital Review13d
Drug inspectors warn of slower checks following FDA layoffs
Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens ...
STAT13d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...